A large proportion of patients with cancer unfortunately have or develop resistance to available therapies, even the newer breakthrough therapies. We are committed to working to address this unmet medical need.
Our commitment includes conducting clinical trials in patients with cancer to demonstrate safety and efficacy of our investigational medicines. Data from these clinical trials ultimately could support regulatory approval, allowing them to become available for the benefit of cancer patients.
Patients who choose to participate in clinical trials play a critical role in the development of these and other new medicines. If you are interested in gaining access to our investigational medicines, we encourage you to speak with your physician about the possibility of enrolling in a clinical trial.